16 reports

  • Haematology Reagent
  • Immunohaematology
  • South Korea
  • Market Segment
  • diaDexus, Inc.

Japan Haematology Market Outlook to 2021 Reference Code: GDMECC##DB Publication Date: October 2015 ## ## ## ## ## ## ## ## Introduction Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms of revenues, distributors and competitors.

  • Haematology Reagent
  • In Vitro Diagnostics
  • Japan
  • Market Segment
  • Noemalife

Australia Haematology Market Outlook to 2021 Reference Code: GDMECC##DB Publication Date: October 2015 ## ## ## ## ## ## ## ## Introduction Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms of revenues, distributors and competitors.

  • Haematology Reagent
  • In Vitro Diagnostics
  • Australia
  • Company
  • NuSep Holdings Ltd
  • Haematology Reagent
  • In Vitro Diagnostic Reagent
  • Italy
  • Market Segment
  • Noemalife
  • Haematology Reagent
  • Immunohaematology
  • United Kingdom
  • Market Segment
  • Noemalife
  • Haematology Reagent
  • Immunohaematology
  • Germany
  • Market Segment
  • Noemalife

Steve Young, Professor of Pathology, Department of Pathology UNMHSC and Tricore Reference Lab.

  • Haematology Reagent
  • Immunohaematology
  • France
  • Market Segment
  • Noemalife
  • Haematology Reagent
  • Immunohaematology
  • Spain
  • Market Segment
  • Noemalife

On the business front, Rosetta Genomics recently announced that Columbia University Medical Center' s Molecular Pathology Laboratory has submitted the first microRNA-based test based on the company' s microRNA technology for regulatory approval to the New York State Department of He

  • Haematology Reagent
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • China
  • Noemalife

India Haematology Market Outlook to 2021 Reference Code: GDMECC##DB Publication Date: August 2015 ## ## ## ## ## ## ## ## Introduction Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms of revenues, distributors and competitors.

  • Haematology Reagent
  • In Vitro Diagnostics
  • India
  • Market Segment
  • Noemalife

Steve Young, Professor of Pathology, Department of Pathology UNMHSC and Tricore Reference Lab.

  • Haematology Reagent
  • In Vitro Diagnostic Reagent
  • Laboratory Equipment
  • Asia
  • Sysmex Corporation
  • Haematology Reagent
  • Immunohaematology
  • In Vitro Diagnostic Reagent
  • United States
  • OPKO Health, Inc.

Steve Young, Professor of Pathology, Department of Pathology UNMHSC and Tricore Reference Lab.

  • Haematology Reagent
  • Laboratory
  • North America
  • United States
  • BioTime, Inc.

Noemalife' s solutions include LIMS/ LIS, Flow Cytometry, Validation/ Appropriateness, Genetics, Anatomic Pathology, Microbiology, Middleware/ Laboratory Automation System, Screening, Medical Imaging/ RIS, other Clinical Services, among others.

  • Haematology Reagent
  • Immunohaematology
  • Mexico
  • Market Segment
  • HORIBA, Ltd.

Noemalife' s solutions include LIMS/ LIS, Flow Cytometry, Validation/ Appropriateness, Genetics, Anatomic Pathology, Microbiology, Middleware/ Laboratory Automation System, Screening, Medical Imaging/ RIS, other Clinical Services, among others.

  • Haematology Reagent
  • In Vitro Diagnostic Reagent
  • Canada
  • Company
  • Amorfix Life Sciences Ltd.

Steve Young, Professor of Pathology, Department of Pathology UNMHSC and Tricore Reference Lab.

  • Haematology Reagent
  • In Vitro Diagnostic Reagent
  • Europe
  • Forecast
  • Novartis AG